Description
According to researchers, our growth hormone production decreases by about 15% each decade after we reach the age of 30. This means that by the age of 50, production is already down by 30%. Using a blend of CJC-1295 and Ipamorelin can help increase growth hormone production. Why take them as a blend? Each Peptide affects growth hormone production through different pathways, allowing for the largest possible boost in growth hormone levels. Sarmsamerica manufactures blended CJC-1295 and Ipamorelin for sale at the highest quality and potency available.
This popular blend of Ipamorelin and CJC-1295 from Sarmsamerica is ideal for achieving higher levels of growth hormone. Our product contains 5 mg of each lyophilized Peptide , for a total of 10 mg per vial.
Why Combine CJC 1295 & Ipamorelin?
Although you may think that both Peptides do the exact same thing, making it redundant to use both at the same time, they actually work in different ways. For example, while Ipamorelin stimulates the production and release of growth hormone by binding to ghrelin receptors, CJC-1295 binds to growth hormone-releasing hormone receptors. So, while they essentially aim to achieve the same outcome, combining both Peptides is likely to produce a more profound effect.
What is CJC 1295?
CJC-1295, also known as Drug Affinity Complex: Growth Hormone-Releasing Factor (DAC: GRF), is a synthetic analogue of Growth Hormone-Releasing Hormone (GHRH). It acts as a growth hormone secretagogue, meaning it induces the secretion of growth hormone. This Peptide was developed by ConjuChem Biotechnologies, a medical biotech company based in Quebec, Canada.
CJC-1295 is known to increase plasma growth hormone and insulin-like growth factor one (IGF-1) levels in both animals and humans. The Peptide has a half-life of approximately six to eight hours, and with multiple doses, IGF-1 levels have been found to remain elevated for up to twenty-eight days. Initial research and trials into CJC-1295 aimed to investigate its potential as a treatment for lipodystrophy and growth hormone deficiency.
What is Ipamorelin?
Ipamorelin, with the developmental code name NNC 26-0161, is a Peptide selective agonist of the ghrelin or growth hormone secretagogue receptor and is considered a growth hormone secretagogue. This means that it binds to the ghrelin or growth hormone secretion receptors and stimulates the production of more growth hormone through a biological response.
Like CJC-1295, Ipamorelin has been proven to increase plasma growth hormone (GH) levels and stimulate body weight gain. Ipamorelin does not affect prolactin, follicle-stimulating hormone, thyroid-stimulating hormone, or luteinizing hormone. It was originally developed by Novo Nordisk, a Danish multinational company. Once it started phase II trials, Helsinn Therapeutics took over and tested it for the treatment of postoperative ileus, a condition characterized by the disruption of normal propulsive ability in the intestines.
For those who may not know, prolactin helps women produce breast milk; follicle-stimulating hormone is a polypeptide that regulates development, pubertal maturation, reproductive processes, and growth; luteinizing hormone is responsible for ovulation in women and Leydig cell production of testosterone in men; and finally, thyroid-stimulating hormone is responsible for producing thyroxin and triiodothyronine, which stimulate metabolism.
This preparation is for in vitro laboratory research purposes, not for human consumption, only by licensed professionals and is not approved by the FDA for bodily introduction of any kind into humans or animals. CJC 1295/Ipamorelin Blend is not a compound, food, supplement, or cosmetic and may not be misbranded, misused, or mislabeled as such.
CJC 1295 Ipamorelin FAQs
What is CJC 1295 Ipamorelin?
CJC-1295 Ipamorelin is a combination of two Peptides that function as a Growth Hormone-Releasing Hormone (GHRH), stimulating one side of the pituitary gland. These two Peptides work together to increase the production of human growth hormone (HGH) in the body. The CJC-1295/Ipamorelin combo achieves this by targeting two different families of receptors, enhancing the overall effectiveness of HGH production.
How should CJC-1295/Ipamorelin be used?
CJC-1295/Ipamorelin is injected subcutaneously, or under the skin. The injection is typically taken at night to mimic the natural release cycle of growth hormone.
What are the side effects of CJC1295 / Ipamorelin?
One of the biggest reasons why CJC-1295 is being embraced by so many in their anti-aging regimen is due to the relatively low rate of side effects. Most people tolerate CJC-1295 quite well, and side effects are generally mild, if present at all. The most frequent side effect is an injection site reaction, typically involving skin complaints or mild pain at the site of injection. The most common side effects include: Sensitivity, soreness, or pain at the injection site, Flu-like symptoms, Headache, Dizziness, Nausea, Drowsiness, Flushing, Hives or other skin reactions, Hyperactivity, Difficulty swallowing.
Buy CJC 1295 Ipamorelin Online at Sarmsamerica
At Sarmsamerica, we provide top-quality Peptides, SARMs, and research products for your use. Our Peptides, including CJC-1295 and Ipamorelin, are all pharmaceutical grade. Want to learn more about your Peptides? Head over to our blog to discover everything from what they are to the right dosages. If you have any other questions, feel free to contact our fantastic customer service team today!
